Trial intelligence / Profile preview

Perfluorocarbon (ABL-101) Oxygenation for Stroke: Trial with GOLD Imaging Theranostic (POST-IT)

2017-003232-36Phase 2Unknown

Sponsor
NHS Greater Glasgow and Clyde
Start
Oct 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of perfluoro-tert-butylcyclohexane in brain infarction, ischemic stroke, sponsored by NHS Greater Glasgow and Clyde. Status: unknown.

02

Drugs

perfluoro-tert-butylcyclohexane
03

Conditions

brain infarctionischemic stroke

Beyond the preview

Go deeper on 2017-003232-36.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2017-003232-36.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call